Loyal

📍 San Francisco, United States🗓 Founded 2020👥 204 employees💰 Last funded Feb 2024
Biotechnology Research🌐 loyal.com
Website LinkedIn
Loyal is a clinical-stage veterinary medicine company developing drugs intended to extend the lifespan and healthspan of dogs. In other words, our mission is to help dogs live longer, healthier lives. We’ve already achieved significant milestones on our path to gaining FDA approval for the first lifespan extension drug for any species. We have three products in our pipeline and expect to bring the first product to market in 2025. Our team includes scientists, veterinarians, engineers, operators, and creatives. Join us in our mission to help dogs everywhere.
5
Total investors
4
Early stage
1
Mid stage
0
Late stage
2020
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
5
Investor activity2019–2024 · investors recorded per year
201912020320241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Loyal?
Loyal has 5 investors on record on gritt.io, including 4 early-stage backers, 1 mid-stage.
When did Loyal last raise funding?
The most recent investment in Loyal recorded on gritt.io was in February 2024.
When was Loyal founded?
Loyal was founded in 2020.
What industry is Loyal in?
Loyal operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Loyal based?
Loyal is headquartered in San Francisco, United States.